These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2507219

  • 1. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE, Henderberg A, Sanders CV.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [Abstract] [Full Text] [Related]

  • 2. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE, Henderberg A, Gebbia K, Schiro DD, Janney A, Sanders CV.
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN, Saxon B, Matsen JM.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
    DiVincenzo CA, Shatzer KL, Venezio FR.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
    Rossolini GM, Valentini S, Satta G.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 8. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of lomefloxacin as compared with ciprofloxacin.
    Inderlied CB, Lancero MG, Bermudez LM, Young LS.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):17S-20S. PubMed ID: 2791493
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
    Torres JR.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
    Sonstein SA, Dahlgren J.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
    Cornaglia G, Ligozzi M, Pelosi E, Canepari P, Fontana R.
    J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
    [Abstract] [Full Text] [Related]

  • 13. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN, Sarachian B, Fernandez A, Paolasso R, Kaufman C, Notario R, Porven G, Ingaramo RA, Perez S, Ferrero SM.
    Diagn Microbiol Infect Dis; 1989 Apr; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [Abstract] [Full Text] [Related]

  • 14. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
    Jones RN, Aldridge KE, Barry AL, Fuchs PC, Gerlach EH, Pfaller MA, Washington JA.
    Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
    [Abstract] [Full Text] [Related]

  • 15. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 16. Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
    Weinstein MP.
    Diagn Microbiol Infect Dis; 1988 Dec; 11(4):195-200. PubMed ID: 3071448
    [Abstract] [Full Text] [Related]

  • 17. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
    Hoban D, Grabowski M, Koss J, Weselowski V.
    Diagn Microbiol Infect Dis; 1989 Dec; 12(3 Suppl):77S-82S. PubMed ID: 2791502
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Wise R, Andrews JM, Ashby JP, Matthews RS.
    Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM, Müller S, Kipp J, Stille W.
    Diagn Microbiol Infect Dis; 1989 May; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial and plasmid curing activity of lomefloxacin in vitro.
    Derlot E, Poyart-Salmeron C, Courvalin P.
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1048-52. PubMed ID: 2515963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.